Viridian Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2024 | — | -99,018.2% | -89,387.1% |
| FY2025 | — | -512.9% | -483.6% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2024 | — | -99,018.2% | -89,387.1% |
| FY2025 | — | -512.9% | -483.6% |